Novel immune checkpoint holds ‘great promise’ as melanoma treatment targetJune 25, 2019MelanomaImmunotherapy
AML variants before transplant signal need for aggressive therapyJune 25, 2019Leukemia, Myelodysplasia, Transplantation
For tough AML, half respond to selinexor plus chemotherapyJune 25, 2019Leukemia, Myelodysplasia, Transplantation
Hedgehog signaling offers prognostic, therapeutic potential in CLLJune 25, 2019Leukemia, Myelodysplasia, Transplantation
Trump administration seeks more health care cost details for consumersJune 25, 2019Practice Management
CVD risk upped in postmenopausal breast cancer survivorsJune 24, 2019Breast CancerPreventive CarePatient & Survivor Care
Immunotherapy-treated NSCLC: Adverse impact of steroids driven by palliative indicationsJune 24, 2019Lung CancerPatient & Survivor Care
Bispecific CAR T-cell therapy yields complete responses in relapsed/refractory non-Hodgkin lymphomasJune 21, 2019ImmunotherapyLymphoma & Plasma Cell DisordersImmuno-oncologyLeukemia, Myelodysplasia, Transplantation
APHINITY trial: Biomarker analysis IDs predictive, prognostic factorsJune 21, 2019Breast CancerImmuno-oncology
Good health goes beyond having a doctor and insurance, says AMA’s equity chiefJune 20, 2019Practice Management
